Opt-e-scrip Inc.
This article was originally published in Start Up
Executive Summary
Successful clinical trials are no guarantee that today's blockbusters will work in the general population. Opt-e-scrip Inc. has developed a method by which doctors can assess true drug response in their patients: statistically valid single-patient clinical trials designed to measure individual reactions to FDA-approved drugs.